M N400 (Nevirapine Extended-Release 400 mg)
Pill with imprint M N400 is White, Elliptical/Oval and has been identified as Nevirapine Extended-Release 400 mg. It is supplied by Mylan Pharmaceuticals Inc.
Nevirapine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M N400
Nevirapine Extended-Release
- Imprint
- M N400
- Strength
- 400 mg
- Color
- White
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- NNRTIs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-4890
- Inactive Ingredients
-
lactose monohydrate,
sodium stearyl fumarate
Note: Inactive ingredients may vary.
Related Images for "M N400"
More about nevirapine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (6)
- Drug images
- Pricing & coupons
- En español
- Drug class: NNRTIs
Patient resources
- Drug Information
- Nevirapine (Advanced Reading)
- Nevirapine Extended-Release Tablets
- Nevirapine Tablets
- Nevirapine Oral Suspension
- Other brands
- Viramune, Viramune XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.